Risk factors and survival outcome in cerebral metastatic breast cancer.

about

Risk factors and survival outcome in cerebral metastatic breast cancer.

Item

http://www.wikidata.org/entity/Q54379038

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Risk factors and survival outcome in cerebral metastatic breast cancer.

@en

Risk factors and survival outcome in cerebral metastatic breast cancer.

@nl

type

Item

label

Risk factors and survival outcome in cerebral metastatic breast cancer.

@en

Risk factors and survival outcome in cerebral metastatic breast cancer.

@nl

prefLabel

Risk factors and survival outcome in cerebral metastatic breast cancer.

@en

Risk factors and survival outcome in cerebral metastatic breast cancer.

@nl

P1476

Risk factors and survival outcome in cerebral metastatic breast cancer.

@en

P2093

A Staebler

http://www.w3.org/2001/XMLSchema#string

C Bachmann

http://www.w3.org/2001/XMLSchema#string

D Wallwiener

http://www.w3.org/2001/XMLSchema#string

E M Grischke

http://www.w3.org/2001/XMLSchema#string

J Schittenhelm

http://www.w3.org/2001/XMLSchema#string

S Schmidt

http://www.w3.org/2001/XMLSchema#string

P2860

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer

Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review

Multifactorial central nervous system recurrence susceptibility in patients with HER2-positive breast cancer: epidemiological and clinical data from a population-based cancer registry study.

HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer

The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases

Estrogen and HER-2 receptor discordance between primary breast cancer and metastasis.

Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumors.

Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer.

P2888

s12032-014-0862-2

P304

862

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-014-0862-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24504842

http://www.w3.org/2001/XMLSchema#string